Follow
Patrick Ingiliz
Patrick Ingiliz
ZIBP
Verified email at zibp.de - Homepage
Title
Cited by
Cited by
Year
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
10872019
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
T Poynard, P Lebray, P Ingiliz, A Varaut, B Varsat, Y Ngo, P Norha, ...
BMC gastroenterology 10, 1-13, 2010
2502010
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
P Ingiliz, TC Martin, A Rodger, HJ Stellbrink, S Mauss, C Boesecke, ...
Journal of hepatology 66 (2), 282-287, 2017
2102017
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus‐1 mono‐infected patients on antiretroviral therapy
P Ingiliz, MA Valantin, C Duvivier, F Medja, S Dominguez, F Charlotte, ...
Hepatology 49 (2), 436-442, 2009
1692009
Treating chronic hepatitis delta: the need for surrogate markers of treatment efficacy
C Yurdaydin, Z Abbas, M Buti, M Cornberg, R Esteban, O Etzion, EJ Gane, ...
Journal of Hepatology 70 (5), 1008-1015, 2019
1222019
Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers
T Poynard, P Ingiliz, L Elkrief, M Munteanu, P Lebray, R Morra, ...
PloS one 3 (12), e3857, 2008
1192008
Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: the Hepatitis Delta International Network (HDIN)
A Wranke, LM Pinheiro Borzacov, R Parana, C Lobato, S Hamid, ...
Liver International 38 (5), 842-850, 2018
1022018
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load
Y Ngo, Y Benhamou, V Thibault, P Ingiliz, M Munteanu, P Lebray, ...
PLoS One 3 (7), e2573, 2008
982008
Biomarkers of liver fibrosis
T Poynard, R Morra, P Ingiliz, F Imbert‐Bismut, D Thabut, D Messous, ...
Advances in Clinical Chemistry 46, 131-160, 2008
922008
Sofosbuvir and ledipasvir for 8 weeks for the treatment of chronic hepatitis C virus (HCV) infection in HCV-monoinfected and HIV-HCV–coinfected individuals: Results from the …
P Ingiliz, S Christensen, T Kimhofer, D Hueppe, T Lutz, K Schewe, ...
Clinical infectious diseases 63 (10), 1320-1324, 2016
902016
Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases
F Nascimbeni, P Lebray, L Fedchuk, CP Oliveira, MR Alvares-da-Silva, ...
Clinical Gastroenterology and Hepatology 13 (4), 763-771. e6, 2015
852015
Ledipasvir–sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial
JK Rockstroh, S Bhagani, RH Hyland, C Yun, H Dvory-Sobol, W Zheng, ...
The lancet Gastroenterology & hepatology 2 (5), 347-353, 2017
832017
Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia
M Lemoine, Y Shimakawa, R Njie, HF Njai, S Nayagam, M Khalil, ...
Alimentary pharmacology & therapeutics 39 (2), 188-196, 2014
802014
Efficacy of direct-acting antivirals for chronic hepatitis C virus infection in people who inject drugs or receive opioid substitution therapy: a systematic review and meta …
C Graf, MM Mücke, G Dultz, KH Peiffer, A Kubesch, P Ingiliz, S Zeuzem, ...
Clinical Infectious Diseases 70 (11), 2355-2365, 2020
742020
Diagnostic accuracy of noninvasive markers of steatosis, NASH, and liver fibrosis in HIV-monoinfected individuals at risk of nonalcoholic fatty liver disease (NAFLD): results …
M Lemoine, L Assoumou, S De Wit, PM Girard, MA Valantin, C Katlama, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (4), e86-e94, 2019
742019
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa
Y Shimakawa, R Njie, G Ndow, M Vray, PS Mbaye, P Bonnard, R Sombié, ...
Journal of hepatology 69 (4), 776-784, 2018
732018
Assessment of liver fibrosis: noninvasive means
T Poynard, R Morra, P Ingiliz, F Imbert-Bismut, D Thabut, D Messous, ...
Saudi Journal of Gastroenterology 14 (4), 163-173, 2008
692008
Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: current incidence rates, compared with …
P Ingiliz, MH Wehmeyer, C Boesecke, J Schulze Zur Wiesch, K Schewe, ...
Clinical Infectious Diseases 71 (5), 1248-1254, 2020
682020
An effective interferon‐gamma‐mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in …
P Kokordelis, B Krämer, C Körner, C Boesecke, E Voigt, P Ingiliz, ...
Hepatology 59 (3), 814-827, 2014
642014
A highly virulent variant of HIV-1 circulating in the Netherlands
C Wymant, D Bezemer, F Blanquart, L Ferretti, A Gall, M Hall, T Golubchik, ...
Science 375 (6580), 540-545, 2022
602022
The system can't perform the operation now. Try again later.
Articles 1–20